NEW YORK, Sept. 3 (GenomeWeb News) -- Ciphergen Biosystems of Fremont, Calif., and the University of Texas Medical Branch-Galveston today announced funding from the National Institutes of Health to develop new strategies for the early diagnosis of viral infections caused by exposure to bioterrorism agents.
The amount of the funding was not disclosed.
The funding was based on data submitted from a prototype thioaptamer array, which combines UTMB's proprietary technology with Ciphergen's SELDI protein chip technology. The collaborators will atempt to identify and characterize novel protein interactions associated with viral infection in response to pathogens.